Infinity Pharmaceuticals Inc (INFI)

1.43
0.03 2.10
NASDAQ : Health Care
Prev Close 1.40
Open 1.41
Day Low/High 1.40 / 1.43
52 Wk Low/High 1.24 / 10.85
Volume 47.16K
Avg Volume 466.80K
Exchange NASDAQ
Shares Outstanding 50.44M
Market Cap 72.13M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Short Interest In Infinity Pharmaceuticals Declines 17.6%

The most recent short interest data has been released for the 04/13/2017 settlement date, which shows a 591,228 share decrease in total short interest for Infinity Pharmaceuticals Inc , to 2,765,545, a decrease of 17.61% since 03/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Updated Phase 1 Data For IPI-549 Presented At AACR Annual Meeting 2017

- IPI-549 Was Well Tolerated as a Monotherapy and in Combination with Opdivo® in Patients with Advanced Solid Tumors -

Infinity Announces Presentation On IPI-549 At AACR Annual Meeting

- Poster Presentation to Include Updated Data from Ongoing Phase 1 Study of IPI-549 in Patients with Advanced Solid Tumors -

Dow Needs to Hit 20K to Shake Things Up

Market has fallen into a dull pattern.

Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy

Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy

Insiders at Infinity Pharmaceuticals and Och-Ziff Capital Management Group -- among other companies -- have been scooping up shares of their own stock lately.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies -- including Wynn Resorts and Virtu Financial -- have been scooping up shares of their own stock lately.

Notable Friday Option Activity: INFI, RSO, P

Notable Friday Option Activity: INFI, RSO, P

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Infinity Pharmaceuticals Inc , where a total volume of 7,196 contracts has been traded thus far today, a contract volume which is representative of approximately 719,600 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 130.3% of INFI's average daily trading volume over the past month, of 552,295 shares.

Verastem Licenses Duvelisib From Infinity Pharmaceuticals

Verastem Licenses Duvelisib From Infinity Pharmaceuticals

Verastem, Inc. (NASDAQ:VSTM) and Infinity Pharmaceuticals, Inc.

Short Interest Jumps 24.6% For INFI

Short Interest Jumps 24.6% For INFI

The most recent short interest data has been released for the 10/14/2016 settlement date, which shows a 408,920 share increase in total short interest for Infinity Pharmaceuticals Inc , to 2,067,803, an increase of 24.65% since 09/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Infinity Pharmaceuticals (INFI) Stock Rises on 'Favorable' Cancer Drug Trial Results

Infinity Pharmaceuticals (INFI) Stock Rises on 'Favorable' Cancer Drug Trial Results

Infinity Pharmaceuticals (INFI) said preliminary results from its IPI-549 drug trial showed that the cancer treatment can reverse tumor resistance to checkpoint inhibitors.

7 Stocks Under $10 to Trade for Big Post-Brexit Gains

7 Stocks Under $10 to Trade for Big Post-Brexit Gains

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Infinity Pharmaceuticals (INFI) Highlighted As Weak On High Volume

Infinity Pharmaceuticals (INFI) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Infinity Pharmaceuticals (INFI) as a weak on high relative volume candidate

Infinity Pharmaceuticals Faces Downgrades as Drug Results Disappoint

Infinity Pharmaceuticals Faces Downgrades as Drug Results Disappoint

Analysts cut valuation estimates for Infinity Pharmaceuticals after a disappointing drug study.

Infinity Pharmaceuticals Cannot Cure Downgrades After Drug Study

Analysts cut valuation estimates after a disappointing drug study. 

Strong On High Volume: Infinity Pharmaceuticals (INFI)

Strong On High Volume: Infinity Pharmaceuticals (INFI)

Trade-Ideas LLC identified Infinity Pharmaceuticals (INFI) as a strong on high relative volume candidate

Why Infinity Pharmaceuticals (INFI) Stock Is Tanking Today

Why Infinity Pharmaceuticals (INFI) Stock Is Tanking Today

Infinity Pharmaceuticals (INFI) stock is plunging after the company announced a restructuring following disappointing drug-study results.

Morning Movers: BIDU, WGP, NERV, INFI

Stocks were falling slightly in premarket trading Tuesday as oil continued its six-day descent.

Infinity Pharmaceuticals is Now Oversold (INFI)

Infinity Pharmaceuticals is Now Oversold (INFI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

8 Stocks Under $10 to Trade for Big Gains

8 Stocks Under $10 to Trade for Big Gains

These under-$10 stocks are making big moves higher. Here's how to trade them from here.

Short Interest Falls 21.2% For INFI

Short Interest Falls 21.2% For INFI

The most recent short interest data has been released by the NASDAQ for the 03/31/2016 settlement date, which shows a 1,155,480 share decrease in total short interest for Infinity Pharmaceuticals Inc , to 4,282,662, a decrease of 21.25% since 03/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.